When Mid Wynd’s (MWY) board announced it had selected Lazard to take over from Artemis as the trust’s portfolio manager, it came as a surprise. The investment firm hasn’t managed an investment trust for many years and isn’t well-known among investors.
Despite this, Russell Napier, Chairman of Mid Wynd, says Lazard represented the clearest continuity from Artemis in terms of style, experience and record.
MoneyWeek
Subscribe to MoneyWeek today and get your first six magazine issues absolutely FREE
Sign up to Money Morning
Don't miss the latest investment and personal finances news, market analysis, plus money-saving tips with our free twice-daily newsletter
Don't miss the latest investment and personal finances news, market analysis, plus money-saving tips with our free twice-daily newsletter
The managers are supported by an internal research team of 20. They have been investing in this style since January 2011, generating an annualised return, net of their proposed fee, of 12.4%, 2.4% ahead of the MSCI All Countries World Index.
Lazard portfolio overview
“Lots of managers say they invest in high-quality companies,” says Florentin-Lee “but many are not clear what that means. As well as analysing cash returns, we seek to understand the competitive advantage of companies We are value-conscious but valuation on its own is never a good reason to buy a stock.”
Lazard's portfolio turnover is 10-15% per annum, less than at Artemis. The portfolio has 41 holdings and the overlap with the benchmark index is just 10%.
- A total of 68% of the portfolio is in North America, 11% in Europe, 7.5% in emerging markets, 6% in Japan and just 2.4% in the UK – represented by RELX. The rest is in developed Asia and cash.
- Information technology accounts for 25% of the portfolio, industrials for 20%, financials 18% and healthcare 13%.
- Consumer stocks are 12% and communications services 7% but this doesn’t include any telecoms
“We have never invested in energy, utilities, mining, telecoms, or real estate,” says Florentin-Lee. Also, “we are only interested in companies with a profitable business model, not companies that seek to grow into profits.”
At the other end of the spectrum, “the worst place to put your money, according to our research, is in the cheapest companies. Cheapness indicates market concern about the sustainability of returns.”
Competitive advantage
The portfolio is full of recognisable names such as Alphabet, Coca-Cola, Visa and Microsoft but some are less well-known. Shimano, for example, has a dominant share of the global market for bicycle components, Iqvia is a market leader in contract research for pharmaceutical companies and Toei is a world leader in content animation.
ASML dominates the market for machines that enable the manufacture of computer chips, TSMC is a world leader in semiconductor manufacture and Zoetis is the largest animal healthcare company in the world. These and the other portfolio constituents clearly fit the managers’ criteria.
A lot of managers are charging into “quality” which raises the concern that it will become over-priced. However, the appeal of get-rich-quick strategies is seductive – either chasing growth at any price or believing that cheap shares will be suddenly re-rated when other investors catch on.
The long, steady march of solid returns may just be too boring for investors focused on the noise of the market, quarterly earnings and economics. “The market tends to think that competitive advantage will be whittled away over time but history shows otherwise. All you need is for companies to hold their multiples and just keep growing.”
The Board of Mid Wynd have chosen well – a management team that promises to maintain Artemis’s good record and, with lower portfolio turnover, perhaps even improve on it.
This article was first published in MoneyWeek's magazine. Enjoy exclusive early access to news, opinion and analysis from our team of financial experts with a MoneyWeek subscription.
-
What is the 25x retirement rule and does it work?The 25x retirement rule has been around for decades but many experts question if it is a suitable strategy
-
When is the self-assessment tax return deadline?If you are self-employed, rent out a property or earn income from savings or investments, you may need to complete a self-assessment tax return. We run through the deadlines you need to know about
-
Are wealthy whisky enthusiasts leaving Britain?Collectables Wealthy whisky enthusiasts are heading to tax-friendly countries such as Dubai, where there is more disposable income to spend on collectable luxuries like rare whisky.
-
'The rise and fall of Kodak is a lesson for the tech giants'Opinion The long decline of Kodak – a once-dominant company – shows why no business is safe from disruption, says Matthew Lynn
-
8 of the best properties for sale with kitchen gardensThe best properties for sale with kitchen gardens – from a 17th-century timber-framed hall house in Norfolk, to an Arts & Crafts house in West Sussex designed by Charles Voysey with a garden by Gertrude Jekyll
-
Why investors can no longer trust traditional statistical indicatorsOpinion The statistical indicators and data investors have relied on for decades are no longer fit for purpose. It's time to move on, says Helen Thomas
-
Investors rediscover the virtue of value investing over growthGrowth investing, betting on rapidly expanding companies, has proved successful since 2008. But now the other main investment style seems to be coming back into fashion.
-
8 of the best properties for sale with shooting estatesThe best properties for sale with shooting estates – from an estate in a designated Dark Sky area in Ayrshire, Scotland, to a hunting estate in Tuscany with a wild boar, mouflon, deer and hare shoot
-
The most likely outcome of the AI boom is a big fallOpinion Like the dotcom boom of the late 1990s, AI is not paying off – despite huge investments being made in the hope of creating AI-based wealth
-
What we can learn from Britain’s "Dashing Dozen" stocksStocks that consistently outperform the market are clearly doing something right. What can we learn from the UK's top performers and which ones are still buys?
